Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma
Autor: | Ying Hui Zhu, Pinzhu Huang, Mengqing Li, Bao Zhu Zhang, Xin Yuan Guan |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Pulmonary and Respiratory Medicine biology Proportional hazards model business.industry General Medicine Deubiquitinating enzyme 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology Ubiquitin Proteasome Downregulation and upregulation 030220 oncology & carcinogenesis biology.protein Cancer research Immunohistochemistry Medicine Risk factor business Survival analysis |
Zdroj: | Thoracic Cancer. 8:344-349 |
ISSN: | 1759-7706 |
DOI: | 10.1111/1759-7714.12453 |
Popis: | Background Ubiquitin specific peptidase 14 (USP14), a deubiquitinating enzyme, has been documented as a key element to regulate the proteolysis function of proteasomes and an attractive therapeutic target for several cancers. Herein, we elucidate the role of USP14 in predicting the prognosis of patients with esophageal squamous cell carcinoma (ESCC). Methods USP14 expression was detected in ESCC tissues and matched adjacent non-tumorous tissues by quantitative real-time reverse transcription-PCR and immunohistochemistry. Kaplan-Meier survival analysis was used to assess the correlation between USP14 expression and prognosis in ESCC patients. Univariate and multivariate analysis was conducted with a Cox proportional hazards model to determine whether USP14 is an independent prognostic factor. Result Overexpression of USP14 was observed in approximately 60% of tested ESCC samples compared to their paired non-tumor esophageal tissues at both RNA and protein levels, and was significantly associated with distant metastasis (P = 0.001). Kaplan-Meier analysis showed that USP14 overexpression was related to poorer overall patient survival. Univariate and multivariate analyses demonstrated that USP14 was an independent risk factor for overall survival. Conclusion The findings in this study suggest that USP14 could be used as a potential prognostic marker for ESCC patients. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |